M3 Biotechnology's Series A - IV Round

M3 Biotechnology raised a round of funding on November 01, 2017.

M3 Biotechnology is a therapeutics company that has a novel platform of pharmaceuticals that modifies growth-factor systems. It is a therapeutic approach particularly relevant to neurodegenerative dis…

Articles about M3 Biotechnology's Series A - IV Round: